226 related articles for article (PubMed ID: 20384522)
1. Vaccines as early therapeutic interventions for cancer therapy: neutralising the immunosuppressive tumour environment and increasing T cell avidity may lead to improved responses.
Durrant LG; Pudney V; Spendlove I; Metheringham RL
Expert Opin Biol Ther; 2010 May; 10(5):735-48. PubMed ID: 20384522
[TBL] [Abstract][Full Text] [Related]
2. CCL5 as an adjuvant for cancer immunotherapy.
Lapteva N; Huang XF
Expert Opin Biol Ther; 2010 May; 10(5):725-33. PubMed ID: 20233026
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of T-cell inhibition: implications for cancer immunotherapy.
Mittendorf EA; Sharma P
Expert Rev Vaccines; 2010 Jan; 9(1):89-105. PubMed ID: 20021308
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells as therapeutic vaccines against cancer.
Banchereau J; Palucka AK
Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149
[TBL] [Abstract][Full Text] [Related]
5. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
Berinstein NL
Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive mechanisms in cancer: consequences for the development of therapeutic vaccines.
Gross S; Geldmacher A; Sharav T; Losch F; Walden P
Vaccine; 2009 May; 27(25-26):3398-400. PubMed ID: 19200836
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic cancer vaccines.
Acres B; Paul S; Haegel-Kronenberger H; Calmels B; Squiban P
Curr Opin Mol Ther; 2004 Feb; 6(1):40-7. PubMed ID: 15011780
[TBL] [Abstract][Full Text] [Related]
8. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
Xia D; Moyana T; Xiang J
Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
[TBL] [Abstract][Full Text] [Related]
9. Cancer vaccination.
Del Vecchio M; Parmiani G
Forum (Genova); 1999; 9(3):239-56. PubMed ID: 10504171
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines: preclinical studies and novel strategies.
Palena C; Abrams SI; Schlom J; Hodge JW
Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy of cancer].
Andersen MH; Schmidt H; Gehl J; von der Maase H; Straten P
Ugeskr Laeger; 2002 Jun; 164(23):3008-16. PubMed ID: 12082849
[TBL] [Abstract][Full Text] [Related]
12. Taming cancer by inducing immunity via dendritic cells.
Palucka AK; Ueno H; Fay JW; Banchereau J
Immunol Rev; 2007 Dec; 220():129-50. PubMed ID: 17979844
[TBL] [Abstract][Full Text] [Related]
13. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
14. Cancer immunogene therapy.
Yoshizawa H; Kagamu H; Gejyo F
Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
[TBL] [Abstract][Full Text] [Related]
15. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
16. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
17. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
18. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
19. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic vaccination against human papilloma virus induced malignancies.
van der Burg SH; Melief CJ
Curr Opin Immunol; 2011 Apr; 23(2):252-7. PubMed ID: 21237632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]